These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34823527)

  • 21. Introducing post-discharge malaria chemoprevention (PMC) for management of severe anemia in Malawian children: a qualitative study of community health workers' perceptions and motivation.
    Nkosi-Gondwe T; Robberstad B; Blomberg B; Phiri KS; Lange S
    BMC Health Serv Res; 2018 Dec; 18(1):984. PubMed ID: 30567567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perceptions and utilization of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine in young children in the Chikhwawa District of Malawi: a mixed methods study.
    Ewing VL; Terlouw DJ; Kapinda A; Pace C; Richards E; Tolhurst R; Lalloo DG
    Malar J; 2015 Jan; 14():13. PubMed ID: 25605477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tools to accelerate falciparum malaria elimination in Cambodia: a meeting report.
    Lek D; Callery JJ; Nguon C; Debackere M; Sovannaroth S; Tripura R; Wojnarski M; Piola P; Khean ST; Manion K; Nguon S; Kunkel A; Vernaeve L; Peto TJ; Dantzer E; Davoeung C; Etienne W; Dondorp AM; Tuseo L; von Seidlein L; Guintran JO
    Malar J; 2020 Apr; 19(1):151. PubMed ID: 32293452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing malaria risk exposure in rural Cambodia population using GPS tracking and questionnaires.
    Pepey A; Souris M; Kim S; Obadia T; Chy S; Ea M; Ouk S; Remoue F; Sovannaroth S; Mueller I; Witkowski B; Vantaux A
    Malar J; 2024 Mar; 23(1):75. PubMed ID: 38475843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimating the Size of Populations at High Risk of Malaria in 2 Operational Districts in Cambodia: Household-Based Survey.
    Jacobson JO; Doum D; Lobo NF; Sovannaroth S; Tatarsky A; McIver DJ
    JMIR Public Health Surveill; 2024 Sep; 10():e58584. PubMed ID: 39331420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malaria knowledge and utilization of chemoprophylaxis in the UK population and in UK passengers departing to malaria-endemic areas.
    Behrens RH; Alexander N
    Malar J; 2013 Dec; 12():461. PubMed ID: 24359323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data.
    Bretscher MT; Dahal P; Griffin J; Stepniewska K; Bassat Q; Baudin E; D'Alessandro U; Djimde AA; Dorsey G; Espié E; Fofana B; González R; Juma E; Karema C; Lasry E; Lell B; Lima N; Menéndez C; Mombo-Ngoma G; Moreira C; Nikiema F; Ouédraogo JB; Staedke SG; Tinto H; Valea I; Yeka A; Ghani AC; Guerin PJ; Okell LC
    BMC Med; 2020 Feb; 18(1):47. PubMed ID: 32098634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The feasibility and acceptability of mass drug administration for malaria in Cambodia: a mixed-methods study.
    Peto TJ; Tripura R; Sanann N; Adhikari B; Callery J; Droogleever M; Heng C; Cheah PY; Davoeung C; Nguon C; von Seidlein L; Dondorp AM; Pell C
    Trans R Soc Trop Med Hyg; 2018 Jun; 112(6):264-271. PubMed ID: 29917147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stakeholder perceptions on the deployment of multiple first-line therapies for uncomplicated malaria: a qualitative study in the health district of Kaya, Burkina Faso.
    Hien D; Kaboré JMT; Siribié M; Soulama I; Barry N; Baguiya A; Tiono AB; Tchouatieu AM; Sirima SB
    Malar J; 2022 Jun; 21(1):202. PubMed ID: 35761273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Private sector opportunities and threats to achieving malaria elimination in the Greater Mekong Subregion: results from malaria outlet surveys in Cambodia, the Lao PDR, Myanmar, and Thailand.
    ; Phok S; Phanalasy S; Thein ST; Likhitsup A
    Malar J; 2017 May; 16(1):180. PubMed ID: 28464945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A qualitative study of the feasibility and community perception on the effectiveness of artemether-lumefantrine use in the context of home management of malaria in south-west Nigeria.
    Ajayi IO; Falade CO; Olley BO; Yusuf B; Gbotosho S; Iyiola T; Olaniyan O; Happi C; Munguti K; Pagnoni F
    BMC Health Serv Res; 2008 Jun; 8():119. PubMed ID: 18513447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mass anti-malarial administration in western Cambodia: a qualitative study of factors affecting coverage.
    Pell C; Tripura R; Nguon C; Cheah P; Davoeung C; Heng C; Dara L; Sareth M; Dondorp A; von Seidlein L; Peto TJ
    Malar J; 2017 May; 16(1):206. PubMed ID: 28526019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Choice of health providers and health-seeking behaviour among forest goer population in Myanmar: findings from a cross-sectional household survey.
    Thet MM; Khaing MNT; Zin SS; Thein ST; Tesfazghi K
    Malar J; 2022 Dec; 21(1):382. PubMed ID: 36517905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parasite clearance, cure rate, post-treatment prophylaxis and safety of standard 3-day versus an extended 6-day treatment of artemether-lumefantrine and a single low-dose primaquine for uncomplicated Plasmodium falciparum malaria in Bagamoyo district, Tanzania: a randomized controlled trial.
    Mhamilawa LE; Ngasala B; Morris U; Kitabi EN; Barnes R; Soe AP; Mmbando BP; Björkman A; Mårtensson A
    Malar J; 2020 Jun; 19(1):216. PubMed ID: 32576258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The acceptability of intermittent screening and treatment versus intermittent preventive treatment during pregnancy: results from a qualitative study in Northern Ghana.
    Pell C; Meñaca A; Chatio S; Hodgson A; Tagbor H; Pool R
    Malar J; 2014 Nov; 13():432. PubMed ID: 25404126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First trimester use of artemisinin-based combination therapy and the risk of low birth weight and small for gestational age.
    Augusto O; Stergachis A; Dellicour S; Tinto H; Valá A; Ruperez M; Macete E; Nakanabo-Diallo S; Kazienga A; Valéa I; d'Alessandro U; Ter Kuile FO; Calip GS; Ouma P; Desai M; Sevene E
    Malar J; 2020 Apr; 19(1):144. PubMed ID: 32268901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug treatment and prevention of malaria in pregnancy: a critical review of the guidelines.
    Al Khaja KAJ; Sequeira RP
    Malar J; 2021 Jan; 20(1):62. PubMed ID: 33485330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence on anti-malarial and diagnostic markets in Cambodia to guide malaria elimination strategies and policies.
    ; Phok S; Lek D
    Malar J; 2017 Apr; 16(1):171. PubMed ID: 28438204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cambodia malaria indicator survey 2020: Implications for malaria elimination.
    Kheang ST; Por I; Sovannaroth S; Dysoley L; Chea H; Po L; AlMossawi HJ; Imran AA; Kak N
    Malariaworld J; 2021; 12():5. PubMed ID: 34532228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting high risk forest goers for malaria elimination: a novel approach for investigating forest malaria to inform program intervention in Vietnam.
    Canavati SE; Kelly GC; Quintero CE; Vo TH; Tran LK; Ngo TD; Tran DT; Edgel KA; Martin NJ
    BMC Infect Dis; 2020 Oct; 20(1):757. PubMed ID: 33059623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.